Malignant fibrous histiocytoma overview: Difference between revisions
No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{Malignant fibrous histiocytoma}} | {{Malignant fibrous histiocytoma}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{NM}} | ||
==Overview== | ==Overview== | ||
'''Malignant fibrous histiocytoma''' (MFH) is a type of [[cancer]] that is the most common [[Sarcoma|soft tissue sarcoma]] of late adult life, most commonly occurring between age 50-70. In rare cases MFH does occur in children, but it is usually in a less aggressive form. However, malignant tumors have occurred in children as young as 13. It occurs more often in caucasians than those of African or Asian descent. Its male:female predominance is 2:1. | '''Malignant fibrous histiocytoma''' (MFH) is a type of [[cancer]] that is the most common [[Sarcoma|soft tissue sarcoma]] of late adult life, most commonly occurring between age 50-70. In rare cases MFH does occur in children, but it is usually in a less aggressive form. However, malignant tumors have occurred in children as young as 13. It occurs more often in caucasians than those of African or Asian descent. Its male:female predominance is 2:1. | ||
==Historical Perspective== | |||
==Classification== | |||
==Pathophysiology== | |||
==Causes== | |||
==Differentiating Malignant Fibrous Histiocytoma from other Diseases== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Natural History, Complications and Prognosis== | |||
==Diagnosis== | |||
===Staging=== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory Findings=== | |||
===CT scan=== | |||
===MRI=== | |||
===Other Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | |||
===Surgery=== | |||
===Secondary Prevention=== | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 19:49, 17 December 2015
|
Malignant fibrous histiocytoma Microchapters |
|
Differentiating Malignant Fibrous Histiocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Malignant fibrous histiocytoma overview On the Web |
|
American Roentgen Ray Society Images of Malignant fibrous histiocytoma overview |
|
Directions to Hospitals Treating Malignant fibrous histiocytoma |
|
Risk calculators and risk factors for Malignant fibrous histiocytoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Malignant fibrous histiocytoma (MFH) is a type of cancer that is the most common soft tissue sarcoma of late adult life, most commonly occurring between age 50-70. In rare cases MFH does occur in children, but it is usually in a less aggressive form. However, malignant tumors have occurred in children as young as 13. It occurs more often in caucasians than those of African or Asian descent. Its male:female predominance is 2:1.